Therapeutics compounds for HIV virus infection
US12187753B2 · kind B2 · utility
0Cited by
58References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2023 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Aug 22, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.